Michigan Supreme Court removes exemption in consumer protection law
Michigan Supreme Court ruled in Attorney General v. Eli Lilly and Company that prior decisions (Smith v. Globe Life, Liss v. Lewiston-Richards) improperly broadened exemptions under the Michigan Consumer Protection Act. The ruling sends the case back to Ingham County, allowing AG Dana Nessel’s office to investigate Eli Lilly’s insulin pricing practices. Dissenters argued lack of standing.
How this was made
The 30-second read
Why it matters
By overturning those precedents, the Michigan Supreme Court allows the Attorney General’s office to proceed with an MCPA probe into Eli Lilly’s insulin pricing practices, increasing litigation and investigation risk.
Market read
This is a state-level legal precedent that removes a consumer-protection exemption, directly affecting LLY’s exposure to pricing-related investigations in Michigan.
What to watch
The ruling is procedural and jurisdiction-specific; traders should watch for how quickly subpoenas are issued, whether claims are narrowed, and any parallel federal or multi-state actions that could compound exposure.
Background
Michigan’s Consumer Protection Act previously had judicially recognized exemptions for certain government-regulated business practices, based on Smith v. Globe Life (1999) and Liss v. Lewiston-Richards (2007).
Ticker impact
Michigan Supreme Court ruling overturns prior exemptions and clears the way for state investigators to probe Eli Lilly’s insulin pricing practices.
Bias to downside or higher volatility for LLY as regulatory and legal exposure rises in Michigan.
The court explicitly orders the case back to circuit court, enabling the AG’s office to proceed with an MCPA probe into pricing practices, which can drive legal-cost and settlement risk.
Market effects
Sets a precedent that can broaden consumer-protection exposure for other government-regulated industries facing pricing or business-practice scrutiny.
Increases Michigan-specific enforcement risk for large healthcare and insulin manufacturers.
Moderate, as it is state-level, but it can influence how courts interpret consumer-protection statutes around regulated pricing.
Counterpoint
Even with the exemption removed, the investigation still must prove actionable MCPA violations; outcomes may take time and may not translate into immediate financial penalties.
Key entities
- companyEli Lilly and Company
Subject of the Michigan Supreme Court case enabling investigators to probe insulin pricing practices under the MCPA.
- courtMichigan Supreme Court
Ruled that prior exemptions were incorrectly broadened and ordered the case back to circuit court.
- government_officeMichigan Attorney General Dana Nessel
Launched the investigation and praised the ruling as restoring the MCPA’s purpose.
